Citation Tools
PDFHealth economics
Original research
Cost-effectiveness analysis of penpulimab combined with paclitaxel and carboplatin as a first-line treatment for metastatic squamous non-small cell lung cancer in China
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Cost-effectiveness analysis of penpulimab combined with paclitaxel and carboplatin as a first-line treatment for metastatic squamous non-small cell lung cancer in China